Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Belantamab |
| Trade Name | |
| Synonyms | GSK2857914|GSK-2857914|GSK 2857914 |
| Drug Descriptions |
Belantamab is a monoclonal antibody targeting TNFRSF17 (BCMA), which potentially decreases tumor growth (PMID: 34253590). |
| DrugClasses | TNFRSF17 Antibody 22 |
| CAS Registry Number | 2061894-48-0 |
| NCIT ID | C171828 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Belantamab | Belantamab | 0 | 1 |
| Belantamab + Belantamab mafodotin-blmf + Dexamethasone + Lenalidomide | Belantamab Belantamab mafodotin-blmf Dexamethasone Lenalidomide | 0 | 1 |